Skip to content

Clinical trials

Phase 1/2 Glioblastoma trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 1/2 Country / region: Switzerland Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20132
20141
20151
20162
20171
20181
20213
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Terminated3
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Philogen S.p.A.2
University Hospital, Geneva2
Basilea Pharmaceutica1
BeiGene USA, Inc.1
Bristol-Myers Squibb1
Debiopharm International SA1
European Organisation for Research and Treatment of Cancer - EORTC1
Medical Research Council1
Nerviano Medical Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma15
Gliosarcoma4
Central Nervous System Neoplasms3
Neoplasms3
Astrocytoma2
Brain Neoplasms2
Carcinoma, Ovarian Epithelial1
Colorectal Neoplasms1
Endometrial Neoplasms1
Epilepsy1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.